Latest News

Farokhzad Awarded Nanotechnology Prize

Omid Farokhzad, MD, director of the Laboratory of Nanomedicine and Biomaterials at BWH and associate professor in the Department of Anesthesiology, was recently named one of two 2013 Laureates of the RUSNANOPRIZE, the largest international nanotechnology prize, for his work in advancing nanoparticle technologies. Farokhzad is being recognized in the field of Nanomaterials and Surface Modification for his role in the innovation, development and industrialization of nanoparticle technologies for medical applications.

The award is also given to a company that has achieved significant commercial success due to implementation of the winning research. Given this, the RUSNANOPRIZE also recognizes BIND Therapeutics, cofounded by Farokhzad, for successfully applying his winning research into industrial production. BIND's lead drug candidate is BIND-014, which is a targeted and controlled release nanoparticle in phase II clinical trials for treatment of lung and prostate cancers. BIND-014 is the first targeted and controlled release nanoparticle technology to reach human clinical trial.

Read more at this BWH page.

Farokhzad named a Boston Business Journal 2013 Champion in Healthcare

Three individuals and one division at BWH were named 2013 Champions in Healthcare by the Boston Business Journal, an annual award that honors the leading professionals in Massachusetts’ stellar healthcare industry. The awards will be announced Aug. 16 in the print edition of the BBJ.

Omid Farokhzad, MD, director of the Laboratory of Nanomedicine and Biomaterials, won in the “innovator” category for helping define the health care field with pioneering research or a new procedure.

Over the past decade, Farokhzad has iteratively developed targeted nanoparticles with the potential to treat a wide range of conditions, from solid tumors to cardiovascular conditions. Farokhzad has authored approximately 95 publications and is an inventor of more than 125 US and International patents/patent applications that have formed the foundation for three biotechnology companies.

ajax loader